Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aeglea Biothera (NQ: AGLE )

7.980 USD -0.230 (-2.80%)
Official Closing Price Updated: 4:21 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Aeglea Biothera

< Previous 1 2 3 4 5 6 7 8 Next >
Aeglea BioTherapeutics Announces 1-Year Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 6th Congress of the European Academy of Neurology
From GlobeNewswire News Releases
Aeglea BioTherapeutics to Present Late-Breaking 1-Year Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 6th Congress of the European Academy of Neurology
From GlobeNewswire News Releases
Aeglea BioTherapeutics Reports First Quarter 2020 Financial Results and Corporate Highlights
From GlobeNewswire News Releases
Monday 5/4 Insider Buying Report: F, AGLE
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their... 
Tags Stocks
From Market News Video
Aeglea BioTherapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From GlobeNewswire News Releases
82 Biggest Movers From Yesterday
Gainers Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) shares climbed 69.4% to close at $19.50 on Tuesday after the company presented ... 
Tags SSD SXTC CLSD
From Benzinga
56 Stocks Moving In Tuesday's Mid-Day Session
Gainers Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) shares jumped 68.6% to $19.40 after the company presented positive preclinical ... 
Tags VSTM SSD Intraday Update
From Benzinga
Aeglea BioTherapeutics Announces Pricing of $120 Million Public Offering
From GlobeNewswire News Releases
Aeglea BioTherapeutics Announces Proposed Public Offering
From GlobeNewswire News Releases
Aeglea BioTherapeutics Announces Approval of Clinical Trial Application for its Novel Engineered Human Enzyme Designed to Treat Homocystinuria (ACN00177)
From GlobeNewswire News Releases
Analysts See 37% Gains Ahead For The Holdings of IBB
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Stocks That Hit 52-Week Lows On Monday
On Monday, 2568 stocks hit new 52-week lows. Areas of Significance: Amazon.com(NASDAQ: AMZN)is the largest company ... 
Tags RBA IEA VNDA
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning session, various companies made new 52-week lows. Intriguing Points: Facebook(NASDAQ: ... 
Tags CAJ AIR ERA
From Benzinga
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags BEAT AQST AMAG
From Benzinga
RSI Alert: Aeglea BioTherapeutics (AGLE) Now Oversold
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's morning session, 690 stocks hit new 52-week lows. Intriguing Points: Boeing(NYSE: BA)was the ... 
Tags QHC TDW APY
From Benzinga
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags IBB BHC ANPC
From Benzinga
The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ... 
Tags STIM ARTL CLF
From Benzinga
10 Biggest Price Target Changes For Tuesday
RBC Capital lowered eBay Inc (NASDAQ: EBAY) price target from $37 to $34. eBay closed at $37.26 on Monday. MKM Partners boosted ... 
Tags HPQ REGN RGLD
From Benzinga
AGLE Crosses Below Key Moving Average Level
In trading on Monday, shares of Aeglea BioTherapeutics Inc (AGLE) crossed below their 200 day moving average of $7.58, changing hands as low as $7.26 per share. Aeglea BioTherapeutics Inc shares are... 
Tags Stocks
From Market News Video
Aeglea BioTherapeutics Reports Fourth-Quarter and Full-Year 2019 Financial Results, Highlights Recent Milestones
From GlobeNewswire News Releases
The Math Shows IBB Can Go To $145
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Aeglea BioTherapeutics Breaks Below 200-Day Moving Average - Notable for AGLE
In trading on Monday, shares of Aeglea BioTherapeutics Inc (AGLE) crossed below their 200 day moving average of $7.54, changing hands as low as $7.47 per share. Aeglea BioTherapeutics Inc shares are... 
Tags Stocks
From Market News Video
Aeglea BioTherapeutics Submits CTA Application for its Novel Engineered Human Enzyme Designed to Treat Homocystinuria (ACN00177)
Company Expects to Initiate a Phase 1/2 Trial in the Second Quarter of 2020 
From GlobeNewswire News Releases
Aeglea BioTherapeutics to Present at 38th Annual J.P. Morgan Healthcare Conference
From GlobeNewswire News Releases
Aeglea BioTherapeutics to Participate in Upcoming Investor Conferences
From GlobeNewswire News Releases
AGLE Makes Notable Cross Below Critical Moving Average
In trading on Monday, shares of Aeglea BioTherapeutics Inc (AGLE) crossed below their 200 day moving average of $7.58, changing hands as low as $7.28 per share. Aeglea BioTherapeutics Inc shares are... 
Tags Stocks
From Market News Video
Aeglea BioTherapeutics Reports Third Quarter 2019 Financial Results and Corporate Highlights
From GlobeNewswire News Releases
Aeglea BioTherapeutics Strengthens Leadership Team with Appointment of Ravi M. Rao as Chief Medical Officer and Michael C. Hanley as Chief Commercial Officer
From GlobeNewswire News Releases
Look Under The Hood: UBIO Has 29% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.